Daiichi Sankyo commences Phase I/II/III trial for Covid-19 booster in Japan
Daiichi Sankyo has commenced a Phase I/II/III clinical trial of a booster dose of Covid-19 vaccine, DS-5670, in Japan.
Source: clinicaltrialsarena.com
Page 18 - Key Challenges News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Key Challenges. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Key Challenges Today - Breaking & Trending Today
5G: There should be two consortia like in S'pore | Daily Express Online
Despite the publicity, all sort of advocacy and lobbying by various interested parties involved, the so-called single wholesale network (SWN) model proposition by Digital National Berhad (DNB), as it stands today, doesn’t hold water from the perspectives of nation-building, technical feasibility, financial and commercial viability as well as governance and integrity
Source: dailyexpress.com.my
Eisai enrols first subject in Phase II/III Alzheimer's disease antibody trial
Eisai has enrolled the first subject in Phase II/III Tau NexGen trial of E2814 for dominantly inherited Alzheimer’s disease (DIAD).
Source: clinicaltrialsarena.com
Neurology: Li-Huei Tsai tweet on hippocampus recognising image sequences top tweet in Q3 2021
Clinical Trial Arena lists five of the most popular tweets on neurology in Q3 2021 based on GlobalData’s Pharmaceuticals Influencer Platform.
Source: clinicaltrialsarena.com
Lung Monitoring Devices Market To Discern Magnified Growth During 2022 – 2031
Respiration is an irreplaceable human life process, starting at the time of birth and continuing until death. For many decades, a healthy human body has been able to breathe, but due to rising levels of pollution in metropolitan cities and lifestyles involving cigarette smoking, clogging of airways and other lung st...
Source: pharmiweb.com